Viewing Study NCT05445934


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-30 @ 10:21 AM
Study NCT ID: NCT05445934
Status: UNKNOWN
Last Update Posted: 2023-01-05
First Post: 2022-06-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)
Sponsor: Frontier Biotechnologies Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-09-14
Start Date Type: ACTUAL
Primary Completion Date: 2023-11
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-12
Completion Date Type: ESTIMATED
First Submit Date: 2022-06-27
First Submit QC Date: None
Study First Post Date: 2022-07-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-01-03
Last Update Post Date: 2023-01-05
Last Update Post Date Type: ACTUAL